Mechanism of Colquhounia Root Tablets in inhibiting osteoclast differentiation based on HSP90 target modulation
This study aimed to investigate the potential role of Colquhounia Root Tablets against bone destruction in rheumatoid arthritis (RA) and its molecular mechanism.The study used ultra-performance liquid chromatography-mass spectrometry to analyze the major components of Colquhounia Root Tablets and predicted its candidate target gene set based on the major components.The key targets of RA bone destruction were obtained through GeneCards and the Database of Genetics and Medical Literature (OMIM),protein-protein interaction (PPI) network was constructed,and the key targets were identified by topological analysis.The molecular mechanism of Colquhounia Root Tablets against RA bone destruction was further revealed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis.The effects of Colquhounia Root Tablets on macrophage viability was assessed by MTS assay and screened for non-toxic concentrations.A model of receptor activator of nuclear factor-κB (RANKL) induced osteoclast differentiation in vitro was constructed.Colquhounia Root Tablets were used to observe the formation and differentiation of osteoclasts by tartrate-resistant acid phosphatase (TRAP) staining and fibrous actin(F-actin) staining,and the effects of Colquhounia Root Tablets on the changes of core target proteins in the osteoclast differentiation system were detected by immunofluorescence and Western blot.The results showed that the main components of Colquhounia Root Tablets included 14 compounds such as triptolide,celastrol,and triptophenolide.Further network analysis revealed that heat-shock protein 90 (HSP90) was the key target gene of Colquhounia Root Tablets for anti-RA bone destruction.TRAP staining and F-actin staining showed that the number and area of TRAP-positive polymorphonuclear cells,as well as actin rings,were reduced in a dose-dependent manner after the intervention of Colquhounia Root Tablets (P<0.01).Western blot results showed that the expression of HSP90 protein was significantly reduced after intervention with Colquhounia Root Tablets at 20 and 40 μg·mL-1 (P<0.01);Colquhounia Root Tablets at 10 μg·mL-1 could significantly decrease the expression of necrosis factor receptor associated molecule 6 (TRAF6) and nuclear factor of activated T cells 1 (NFATc1) proteins (P<0.01);moreover,all doses of Colquhounia Root Tablets significantly reduced the expression of osteoclast differentiation marker proteins matrix metalloproteinase 9 (MMP9) and cathepsin K (CTSK) (P<0.01).Immunofluorescence results further confirmed that Colquhounia Root Tablets significantly inhibited HSP90 and CTSK levels,as well as NFATc1 activation in osteoblasts.In conclusion,the present study confirmed that Colquhounia Root Tablets may inhibit RANKL-induced osteoclast differentiation by regulating the key target of HSP90,thus exerting an anti-RA bone destruction effect,which will provide a new idea for Colquhounia Root Tablets to prevent and treat bone destruction in rheumatoid arthritis.
Colquhounia Root Tabletsheat shock protein 90rheumatoid arthritisbone destruction
万方数据
维普
